CSR Fundamental Analysis - CENTERSPACE

Fundamental Rating

Taking everything into account, CSR scores 2 out of 10 in our fundamental rating. CSR was compared to 20 industry peers in the Residential REITs industry. CSR has a bad profitability rating. Also its financial health evaluation is rather negative. CSR does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CSR has reported negative net income.

CSR had a positive operating cash flow in the past year.

CSR had negative earnings in 4 of the past 5 years.

Each year in the past 5 years CSR had a positive operating cash flow.

1.2 Ratios

The Return On Assets of CSR (-1.47%) is worse than 85.00% of its industry peers.

The Return On Equity of CSR (-4.09%) is worse than 75.00% of its industry peers.

The Return On Invested Capital of CSR (0.99%) is worse than 85.00% of its industry peers.

The Average Return On Invested Capital over the past 3 years for CSR is in line with the industry average of 2.59%.

The last Return On Invested Capital (0.99%) for CSR is above the 3 year average (0.95%), which is a sign of increasing profitability.

		Industry Rank	Sector Rank
ROA	-1.47%
ROE	-4.09%
ROIC	0.99%

ROA(3y)-0.08%

ROA(5y)-0.14%

ROE(3y)-0.29%

ROE(5y)-0.39%

ROIC(3y)0.95%

ROIC(5y)0.7%

1.3 Margins

The Operating Margin of CSR (9.21%) is worse than 85.00% of its industry peers.

In the last couple of years the Operating Margin of CSR has grown nicely.

CSR has a Gross Margin of 57.86%. This is comparable to the rest of the industry: CSR outperforms 45.00% of its industry peers.

In the last couple of years the Gross Margin of CSR has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	9.21%
PM (TTM)	N/A
GM	57.86%

OM growth 3Y90.72%

OM growth 5Y6.8%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.86%

GM growth 5Y1.32%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CSR is destroying value.

CSR has more shares outstanding than it did 1 year ago.

The number of shares outstanding for CSR has been increased compared to 5 years ago.

The debt/assets ratio for CSR is higher compared to a year ago.

2.2 Solvency

CSR has an Altman-Z score of 0.14. This is a bad value and indicates that CSR is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of CSR (0.14) is worse than 85.00% of its industry peers.

A Debt/Equity ratio of 1.54 is on the high side and indicates that CSR has dependencies on debt financing.

CSR has a worse Debt to Equity ratio (1.54) than 60.00% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.54
Debt/FCF	N/A
Altman-Z	0.14

ROIC/WACC0.15

WACC6.46%

2.3 Liquidity

CSR has a Current Ratio of 0.22. This is a bad value and indicates that CSR is not financially healthy enough and could expect problems in meeting its short term obligations.

CSR's Current ratio of 0.22 is on the low side compared to the rest of the industry. CSR is outperformed by 65.00% of its industry peers.

A Quick Ratio of 0.22 indicates that CSR may have some problems paying its short term obligations.

CSR's Quick ratio of 0.22 is on the low side compared to the rest of the industry. CSR is outperformed by 60.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.22
Quick Ratio	0.22

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CSR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -78.46%.

Looking at the last year, CSR shows a small growth in Revenue. The Revenue has grown by 3.44% in the last year.

CSR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.03% yearly.

EPS 1Y (TTM)-78.46%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%101.05%

Revenue 1Y (TTM)3.44%

Revenue growth 3Y8.97%

Revenue growth 5Y7.03%

Sales Q2Q%5.39%

3.2 Future

CSR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 37.30% yearly.

CSR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.92% yearly.

EPS Next Y58.65%

EPS Next 2Y37.72%

EPS Next 3Y37.3%

EPS Next 5YN/A

Revenue Next Year4.58%

Revenue Next 2Y3.68%

Revenue Next 3Y2.92%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CSR. In the last year negative earnings were reported.

Also next year CSR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CSR is valued cheaper than 100.00% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	15.44

4.3 Compensation for Growth

A more expensive valuation may be justified as CSR's earnings are expected to grow with 37.30% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y37.72%

EPS Next 3Y37.3%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.20%, CSR is a good candidate for dividend investing.

CSR's Dividend Yield is a higher than the industry average which is at 4.68.

Compared to an average S&P500 Dividend Yield of 2.38, CSR pays a better dividend.

		Industry Rank	Sector Rank
Dividend Yield	5.2%

5.2 History

The dividend of CSR decreases each year by -0.65%.

CSR has paid a dividend for at least 10 years, which is a reliable track record.

CSR has decreased its dividend recently.

Dividend Growth(5Y)-0.65%

Div Incr Years1

Div Non Decr Years1

5.3 Sustainability

CSR has negative earnings and hence a negative payout ratio. The dividend may be in danger.

DP-173.83%

EPS Next 2Y37.72%

EPS Next 3Y37.3%

More info and screens

Find the best dividend stocks

Show peers with best dividend

CENTERSPACE

NYSE:CSR (9/19/2025, 4:22:31 PM)

After market: 58.331 0 (0%)

58.33

+0.13 (+0.22%)

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryResidential REITs

Earnings (Last)08-04 2025-08-04/amc

Earnings (Next)10-27 2025-10-27/amc

Inst Owners87.73%

Inst Owner Change0.08%

Ins Owners0.37%

Ins Owner Change4.31%

Market Cap977.61M

Analysts78.67

Price Target67.58 (15.86%)

Short Float %1.61%

Short Ratio2.52

Dividend

		Industry Rank	Sector Rank
Dividend Yield	5.2%

Yearly Dividend3.24

Dividend Growth(5Y)-0.65%

DP-173.83%

Div Incr Years1

Div Non Decr Years1

Ex-Date06-27 2025-06-27 (0.77)

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)39.65%

Min EPS beat(2)-22.37%

Max EPS beat(2)101.68%

EPS beat(4)1

Avg EPS beat(4)-11.61%

Min EPS beat(4)-76.02%

Max EPS beat(4)101.68%

EPS beat(8)3

Avg EPS beat(8)-25.91%

EPS beat(12)6

Avg EPS beat(12)497.96%

EPS beat(16)8

Avg EPS beat(16)374.71%

Revenue beat(2)1

Avg Revenue beat(2)-0.18%

Min Revenue beat(2)-0.37%

Max Revenue beat(2)0.01%

Revenue beat(4)1

Avg Revenue beat(4)-1.36%

Min Revenue beat(4)-4.79%

Max Revenue beat(4)0.01%

Revenue beat(8)1

Avg Revenue beat(8)-1.33%

Revenue beat(12)4

Avg Revenue beat(12)-0.93%

Revenue beat(16)8

Avg Revenue beat(16)-0.1%

PT rev (1m)-5.05%

PT rev (3m)-6.42%

EPS NQ rev (1m)-14.94%

EPS NQ rev (3m)1.96%

EPS NY rev (1m)10.34%

EPS NY rev (3m)17.89%

Revenue NQ rev (1m)-0.29%

Revenue NQ rev (3m)0.88%

Revenue NY rev (1m)0.33%

Revenue NY rev (3m)0.76%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	3.66
P/FCF	N/A
P/OCF	9.61
P/B	1.36
P/tB	1.36
EV/EBITDA	15.44

EPS(TTM)-0.93

EYN/A

EPS(NY)-0.13

Fwd EYN/A

FCF(TTM)-5.09

FCFYN/A

OCF(TTM)6.07

OCFY10.4%

SpS15.94

BVpS43.04

TBVpS43.04

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.47%
ROE	-4.09%
ROCE	1.26%
ROIC	0.99%
ROICexc	1%
ROICexgc	1.02%
OM	9.21%
PM (TTM)	N/A
GM	57.86%
FCFM	N/A

ROA(3y)-0.08%

ROA(5y)-0.14%

ROE(3y)-0.29%

ROE(5y)-0.39%

ROIC(3y)0.95%

ROIC(5y)0.7%

ROICexc(3y)0.95%

ROICexc(5y)0.71%

ROICexgc(3y)0.96%

ROICexgc(5y)0.71%

ROCE(3y)1.2%

ROCE(5y)0.89%

ROICexcg growth 3Y107.93%

ROICexcg growth 5Y7.08%

ROICexc growth 3Y107.97%

ROICexc growth 5Y7.04%

OM growth 3Y90.72%

OM growth 5Y6.8%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.86%

GM growth 5Y1.32%

F-Score2

Asset Turnover0.13

Health

		Industry Rank	Sector Rank
Debt/Equity	1.54
Debt/FCF	N/A
Debt/EBITDA	8.27
Cap/Depr	170.32%
Cap/Sales	70%
Interest Coverage	0.74
Cash Conversion	75.67%
Profit Quality	N/A
Current Ratio	0.22
Quick Ratio	0.22
Altman-Z	0.14

F-Score2

WACC6.46%

ROIC/WACC0.15

Cap/Depr(3y)101.15%

Cap/Depr(5y)179.12%

Cap/Sales(3y)41.21%

Cap/Sales(5y)77.77%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-78.46%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%101.05%

EPS Next Y58.65%

EPS Next 2Y37.72%

EPS Next 3Y37.3%

EPS Next 5YN/A

Revenue 1Y (TTM)3.44%

Revenue growth 3Y8.97%

Revenue growth 5Y7.03%

Sales Q2Q%5.39%

Revenue Next Year4.58%

Revenue Next 2Y3.68%

Revenue Next 3Y2.92%

Revenue Next 5YN/A

EBIT growth 1Y-5.28%

EBIT growth 3Y107.82%

EBIT growth 5Y14.31%

EBIT Next Year451.97%

EBIT Next 3Y81.11%

EBIT Next 5YN/A

FCF growth 1Y-42.41%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-1.34%

OCF growth 3Y5.35%

OCF growth 5Y7.14%

CENTERSPACE (CSR) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens